About TOGA
The Thoracic Oncology Group of Australasia (TOGA) is the leading lung cancer & mesothelioma clinical trials group in Australia & New Zealand.
Vision
To eliminate thoracic cancers as a source of death, disability and suffering.
Mission
To prevent, treat and cure thoracic cancers through research, clinical trials, education and advocacy.
Values
Courage
To pursue new challenges and novel solutions
Integrity
To exemplify honesty and trustworthiness in all of our operations
Equity
To bring an open mind free of prejudice to every interaction and to strive for equal opportunity
Collaboration
Work with key stakeholders, organisations and community groups who share our aim of defeating thoracic cancer
Creativity & Innovation
Strive for and be open to unique and creative solutions
Our strategic plan for 2022-2025 is centred around building capacity, collaborations and a sustainable organisation to help realise our mission.
Financial Reports
TOGA 2022-2023 Financial Report
Financial report for the year ended 30 June 2023
TOGA 2021-2022 Financial Report
Financial report for the year ended 30 June 2022
TOGA 2020-2021 Financial Report
Financial report for the year ended 30 June 2021
